General form of registration statement for all companies including face-amount certificate companies

SUBSEQUENT EVENTS (Details Narrative)

SUBSEQUENT EVENTS (Details Narrative) - USD ($)			1 Months Ended		2 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Oct. 12, 2018	Feb. 09, 2018	Jan. 31, 2018	Jan. 26, 2018	Feb. 28, 2018	Sep. 30, 2018	Dec. 31, 2017	Dec. 31, 2016
Common shares issued				1,000		2,532,863	2,440,863	1,818,045
Subsequent Event [Member]
Terms of investment agreement description		Under the terms of the Investment Agreement, Northbridge has agreed to provide the Company with up to ten million dollars ($10,000,000) of funding in the form of purchases of shares of the Company’s common stock. Northbridge will only make these purchases after a registration statement on Form S-1 registering these future shares is declared effective by the SEC. . A registration statement on Form S-1 registering these future shares was declared effective by the Securities and Exchange Commission (the “SEC”) on September 12, 2018.
Subsequent Event [Member] \| Debt financing [Member]
Common shares issued			1,000
Subsequent Event [Member] \| Employee compensation [Member]
Common shares issued			1,250
Subsequent Event [Member] \| Distribution agreement [Member]
Common shares issued			10,000
Subsequent Event [Member] \| Consulting Services [Member]
Common stock shares issued for services					500
Subsequent Event [Member] \| Investors [Member]
Common stock shares issued for cash, shares			12,500
Share price			$ 12.00
Common stock shares issued for cash, amount			$ 150,000
Subsequent Event [Member] \| Convertible Promissory Note 1 [Member]
Convertible debt				$ 125,000
Subsequent Event [Member] \| Convertible Promissory Note 2 [Member]
Convertible debt				$ 250,000
Subsequent Event [Member] \| Convertible Promissory Note [Member]
Common stock shares reserved for future issuance for additional consideration				100,000
Event of default, description				In the event the Company fails to make any payment due or to perform any terms of the Notes, the Investors have the right to (i) to declare the full, unpaid balance of the Notes, plus interest and other charges; accruing thereon, immediately due and payable; (ii) to specifically enforce the terms of the Notes by suit in equity; (iii) to bring an action for the unpaid and overdue payments without waiving the right to pursue the principal balance, interest, and additions thereto which are due pursuant to the terms of the Notes; and (iv) to pursue any and all other rights and remedies provided in law or equity
Terms of additional consideration payable				As additional consideration for the Notes, the Company will issue an aggregate of 1,000 shares of the Company’s common stock (the “Inducement Shares”) to the Investors within fifteen (15) days of receipt of funds from the Investors
Subsequent Event [Member] \| Therakine Biodelivery GmbH [Member]
Patent acquired	$ 15,200
Development, Commerialization and License agreement, description	Patent families consisting of approximately 11 patents pending and 1 issued patent.